Literature DB >> 27936816

Altered subjective reward valuation among female heavy marijuana users.

Kathryn R Hefner1, Mark J Starr2.   

Abstract

Maladaptive decision-making is a cardinal feature of drug use, contributing to ongoing use, and reflecting alterations in how drug users assess uncertain reward value. Accumulating evidence indicates the consequences of heavy marijuana use are worse for female versus male animals and humans, but research assessing sex differences in reward-related decision-making among marijuana users remains scarce. We examined sex differences in the subjective valuation of certain and uncertain rewards among heavy marijuana users (52; 26 male and 26 female) and controls (52; 26 male and 26 female). We offered male and female heavy marijuana users and controls monetary rewards of certain and uncertain (probabilistic) values. We measured how preferences for uncertain rewards varied by the objective value of those rewards, moderators of reward uncertainty, Marijuana Group and Sex. Men were more sensitive to changes in the objective value of uncertain rewards than women. However, this effect of Sex differed by Marijuana Group. Female heavy marijuana users were more sensitive to changes in uncertain reward value, particularly when the "stakes" were high (i.e., greater difference between potential uncertain rewards), than female controls. Female heavy marijuana users' sensitivity to changes in the value of high stakes uncertain rewards was comparable to male marijuana users and controls. In contrast, male marijuana users' sensitivity to changes in the value of high stakes uncertain rewards did not differ from male controls. These results suggest sex differences in sensitivity to high risk rewards may be one pathway contributing to severer consequences of heavy marijuana use among women. (PsycINFO Database Record (c) 2017 APA, all rights reserved).

Entities:  

Mesh:

Year:  2016        PMID: 27936816      PMCID: PMC5290194          DOI: 10.1037/pha0000101

Source DB:  PubMed          Journal:  Exp Clin Psychopharmacol        ISSN: 1064-1297            Impact factor:   3.157


  88 in total

1.  Delay discounting of money and alcohol in actively using alcoholics, currently abstinent alcoholics, and controls.

Authors:  N M Petry
Journal:  Psychopharmacology (Berl)       Date:  2001-03       Impact factor: 4.530

Review 2.  A review of delay-discounting research with humans: relations to drug use and gambling.

Authors:  Brady Reynolds
Journal:  Behav Pharmacol       Date:  2006-12       Impact factor: 2.293

3.  Moderate drug use and delay discounting: a comparison of heavy, light, and never smokers.

Authors:  Matthew W Johnson; Warren K Bickel; Forest Baker
Journal:  Exp Clin Psychopharmacol       Date:  2007-04       Impact factor: 3.157

Review 4.  The behavioral- and neuro-economic process of temporal discounting: A candidate behavioral marker of addiction.

Authors:  Warren K Bickel; Mikhail N Koffarnus; Lara Moody; A George Wilson
Journal:  Neuropharmacology       Date:  2013-06-24       Impact factor: 5.250

5.  Stress potentiates early and attenuates late stages of visual processing.

Authors:  Alexander J Shackman; Jeffrey S Maxwell; Brenton W McMenamin; Lawrence L Greischar; Richard J Davidson
Journal:  J Neurosci       Date:  2011-01-19       Impact factor: 6.167

6.  Opioid-, cannabis- and alcohol-dependent women show more rapid progression to substance abuse treatment.

Authors:  Carlos A Hernandez-Avila; Bruce J Rounsaville; Henry R Kranzler
Journal:  Drug Alcohol Depend       Date:  2004-06-11       Impact factor: 4.492

7.  Acute effects of smoked marijuana on decision making, as assessed by a modified gambling task, in experienced marijuana users.

Authors:  Nehal P Vadhan; Carl L Hart; Wilfred G van Gorp; Erik W Gunderson; Margaret Haney; Richard W Foltin
Journal:  J Clin Exp Neuropsychol       Date:  2007-05       Impact factor: 2.475

8.  Prefrontal cortex morphometry in abstinent adolescent marijuana users: subtle gender effects.

Authors:  Krista Lisdahl Medina; Tim McQueeny; Bonnie J Nagel; Karen L Hanson; Tony T Yang; Susan F Tapert
Journal:  Addict Biol       Date:  2009-07-24       Impact factor: 4.280

9.  Balanced placebo design with marijuana: pharmacological and expectancy effects on impulsivity and risk taking.

Authors:  Jane Metrik; Christopher W Kahler; Brady Reynolds; John E McGeary; Peter M Monti; Margaret Haney; Harriet de Wit; Damaris J Rohsenow
Journal:  Psychopharmacology (Berl)       Date:  2012-05-16       Impact factor: 4.530

Review 10.  A unified framework for addiction: vulnerabilities in the decision process.

Authors:  A David Redish; Steve Jensen; Adam Johnson
Journal:  Behav Brain Sci       Date:  2008-08       Impact factor: 21.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.